HLA-DRB3 anticorps (AA 1-266)
HLA-DRB3
Reactivité: Humain
WB, FACS
Hôte: Souris
Polyclonal
unconjugated
-
-
Antigène
Voir toutes HLA-DRB3 Anticorps
-
HLA-DRB3
(Major Histocompatibility Complex, Class II, DR beta 3 (HLA-DRB3))
-
Épitope
-
AA 1-266
-
Reactivité
-
Humain
-
Hôte
-
Souris
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp HLA-DRB3 est non-conjugé
-
Application
-
Western Blotting (WB), Flow Cytometry (FACS)
-
Fonction
-
Mouse polyclonal antibody raised against a full-length human HLA-DRB3 protein.
-
Séquence
-
MVCLKLPGGS SLAALTVTLM VLSSRLAFAG DTRPRFLELR KSECHFFNGT ERVRYLDRYF HNQEEFLRFD SDVGEYRAVT ELGRPVAESW NSQKDLLEQK RGRVDNYCRH NYGVGESFTV QRRVHPQVTV YPAKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKAG VVSTGLIQNG DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SALTVEWRAR SESAQSKMLS GVGGFVLGLL FLGAGLFIYF RNQKGHSGLQ PTGFLS
-
Réactivité croisée
-
Humain
-
Attributs du produit
-
Antibody reactive against mammalian transfected lysate.
-
Immunogène
-
HLA-DRB3 (NP_072049.2, 1 a.a. ~ 266 a.a) full-length human protein.
-
-
-
Indications d'application
-
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Conseil sur la manipulation
-
Aliquot to avoid repeated freezing and thawing.
-
Stock
-
-20 °C
-
Stockage commentaire
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Antigène
-
HLA-DRB3
(Major Histocompatibility Complex, Class II, DR beta 3 (HLA-DRB3))
-
Autre désignation
-
HLA-DRB3 (HLA-DRB3 Produits)
-
Synonymes
-
anticorps HLA-DR3B, anticorps BLA-DRB3, anticorps Bota-DRB01, anticorps Bota-DRB02, anticorps Bota-DRB04, anticorps Bota-DRB07, anticorps Bota-DRB21, anticorps Bota-DRB22, anticorps LA-DRB, anticorps major histocompatibility complex, class II, DR beta 3, anticorps major histocompatibility complex, class II, DRB3, anticorps HLA-DRB3, anticorps BOLA-DRB3
-
Sujet
-
Full Gene Name: major histocompatibility complex, class II, DR beta 3
Synonyms: HLA-DR3B,MGC117330
-
ID gène
-
3125
-
NCBI Accession
-
NM_022555
-
Pathways
-
TCR Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-